Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01844622 · ClinicalTrials.gov registry record · NA
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
A NA study, sponsored by Mt. Sinai Medical Center, Miami.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT01844622 is a NA study that has completed, run by Mt. Sinai Medical Center, Miami. The registered enrollment target is 37 participants.
The verdict
NCT01844622, a NA study, has completed, sponsored by Mt. Sinai Medical Center, Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of the study is to treat patients with on-going slow stomach emptying(gastroesophageal reflux disease), who have failed to respond to standard therapy
Interventions
- OTHER Domperidone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2007-12 |
| Est. Completion | 2015-02-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01844622
The ClinicalTrials.gov registry entry for NCT01844622 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mt. Sinai Medical Center, Miami, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Domperidone is the first listed.
NCT01844622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01844622 about?
NCT01844622 is a clinical study titled "Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying". The purpose of the study is to treat patients with on-going slow stomach emptying(gastroesophageal reflux disease), who have failed to respond to standard therapy
What is the current status of trial NCT01844622?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2007-12. Estimated completion is 2015-02-19.
What interventions are being tested in trial NCT01844622?
The interventions under investigation include: Domperidone (OTHER).
Who is sponsoring clinical trial NCT01844622?
This trial is sponsored by Mt. Sinai Medical Center, Miami, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.